StonvexLoading…
StonvexStonvexStonvexCore line items from SOLV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.32B | $8.25B | $8.20B | $8.13B |
Operating Income | $2.18B | $1.04B | $1.69B | $1.69B |
Net Income | $1.56B | $479.00M | $1.35B | $1.34B |
EPS (Diluted) | $8.88 | $2.76 | $7.79 | $7.78 |
Total Assets | $14.29B | $14.46B | $13.94B | Not available |
Total Liabilities | $9.24B | $11.50B | $2.28B | Not available |
Cash & Equivalents | $878.00M | $762.00M | $194.00M | $61.00M |
Free Cash Flow OCF − CapEx | $-10.00M | $805.00M | $1.63B | $1.43B |
Shares Outstanding | 173.49M | 172.79M | 0 | 172.70M |